Don’t miss the panel : “quantum computing use cases overview” with Jean-Philip Piquemal during the France Quantum event at the Eiffel Tower on June 14.

[...]

Don’t miss the panel : “quantum computing use cases overview” with Jean-Philip Piquemal during the France Quantum event at the Eiffel Tower on June 14.robert@deeptechfounders.com2022-06-09T13:02:34+00:00

Don’t miss tomorrow Iktos’ 2nd annual conference on AI for de novo drug design

[...]

Don’t miss tomorrow Iktos’ 2nd annual conference on AI for de novo drug designrobert@deeptechfounders.com2022-06-09T12:35:27+00:00

Discussion autour de l’ordinateur quantique et de ses applications: ce mois-ci dans Sciences et Avenir

[...]

Discussion autour de l’ordinateur quantique et de ses applications: ce mois-ci dans Sciences et Avenirrobert@deeptechfounders.com2022-06-09T13:00:29+00:00

Don’t miss the Q1 2022 edition of The Codex by Da Vinci Labs and the interview of Jean-Philip Piquemal, our CSO on how to accelerate drugdiscovery with physics-based simulation and quantumcomputing

[...]

Don’t miss the Q1 2022 edition of The Codex by Da Vinci Labs and the interview of Jean-Philip Piquemal, our CSO on how to accelerate drugdiscovery with physics-based simulation and quantumcomputingrobert@deeptechfounders.com2022-06-09T09:32:34+00:00

We have been awarded the prestigious iNov prize for the QuMed project by the Secrétariat général pour l’investissement after a thorough evaluation from Bpifrance in the framework of France2030. QuMed represents an extra 1,5M€ to invest in the development of novel quantum inspired & quantum accelerated algorithms for drugdiscovery. It adds up to the 7,5M€ we have been awarded from the EUeic in October 2021.

[...]

We have been awarded the prestigious iNov prize for the QuMed project by the Secrétariat général pour l’investissement after a thorough evaluation from Bpifrance in the framework of France2030. QuMed represents an extra 1,5M€ to invest in the development of novel quantum inspired & quantum accelerated algorithms for drugdiscovery. It adds up to the 7,5M€ we have been awarded from the EUeic in October 2021.robert@deeptechfounders.com2022-06-09T12:57:40+00:00

Today, our collaborative work on the development of novel drug candidates against Covid-19 made it to Chemical Science, the flagship journal for Royal Society of Chemistry. The paper is in open access, aligned with our vision that Covid-19 treatments shoud be a common good.

[...]

Today, our collaborative work on the development of novel drug candidates against Covid-19 made it to Chemical Science, the flagship journal for Royal Society of Chemistry. The paper is in open access, aligned with our vision that Covid-19 treatments shoud be a common good.robert@deeptechfounders.com2022-06-09T09:27:23+00:00

Thank you Sifted for making us an early stage startup to watch in the field of quantumcomputing !

[...]

Thank you Sifted for making us an early stage startup to watch in the field of quantumcomputing !robert@deeptechfounders.com2022-06-09T09:22:52+00:00

Our CSO, Jean-Philip Piquemal, has been admitted as a Fellow of the Royal Society of Chemistry

[...]

Our CSO, Jean-Philip Piquemal, has been admitted as a Fellow of the Royal Society of Chemistryrobert@deeptechfounders.com2022-06-09T12:23:37+00:00

Hear from Robert Marino, CEO of Qubit Pharmaceuticals, on how they’re advancing drug discovery at GTC21

[...]

Hear from Robert Marino, CEO of Qubit Pharmaceuticals, on how they’re advancing drug discovery at GTC21robert@deeptechfounders.com2022-06-09T12:18:15+00:00

We have been selected by the European Innovation Council and SMEs Executive Agency (EISMEA) to receive a €7.5 million blended funding!

[...]

We have been selected by the European Innovation Council and SMEs Executive Agency (EISMEA) to receive a €7.5 million blended funding!robert@deeptechfounders.com2022-06-09T12:14:18+00:00